Global NK Cell Therapy Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15083471 | Publishing Date : 14-Jan-2020 | No. of pages : 99
Detailed TOC of Global NK Cell Therapy Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by NK Cell Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global NK Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 NK Cell Therapies
1.4.3 NK Cell Directed Antibodies
1.5 Market by Application
1.5.1 Global NK Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Gastrointestinal Diseases
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 NK Cell Therapy Market Perspective (2015-2026)
2.2 NK Cell Therapy Growth Trends by Regions
2.2.1 NK Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 NK Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 NK Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 NK Cell Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key NK Cell Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top NK Cell Therapy Players by Market Size
3.1.1 Global Top NK Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global NK Cell Therapy Market Concentration Ratio
3.2.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2019
3.3 NK Cell Therapy Key Players Head office and Area Served
3.4 Key Players NK Cell Therapy Product Solution and Service
3.5 Date of Enter into NK Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global NK Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global NK Cell Therapy Forecasted Market Size by Type (2021-2026)
5 NK Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global NK Cell Therapy Market Size by Application (2015-2020)
5.2 Global NK Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America NK Cell Therapy Market Size (2015-2020)
6.2 NK Cell Therapy Key Players in North America (2019-2020)
6.3 North America NK Cell Therapy Market Size by Type (2015-2020)
6.4 North America NK Cell Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe NK Cell Therapy Market Size (2015-2020)
7.2 NK Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe NK Cell Therapy Market Size by Type (2015-2020)
7.4 Europe NK Cell Therapy Market Size by Application (2015-2020)
8 China
8.1 China NK Cell Therapy Market Size (2015-2020)
8.2 NK Cell Therapy Key Players in China (2019-2020)
8.3 China NK Cell Therapy Market Size by Type (2015-2020)
8.4 China NK Cell Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan NK Cell Therapy Market Size (2015-2020)
9.2 NK Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan NK Cell Therapy Market Size by Type (2015-2020)
9.4 Japan NK Cell Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia NK Cell Therapy Market Size (2015-2020)
10.2 NK Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia NK Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia NK Cell Therapy Market Size by Application (2015-2020)
11 India
11.1 India NK Cell Therapy Market Size (2015-2020)
11.2 NK Cell Therapy Key Players in India (2019-2020)
11.3 India NK Cell Therapy Market Size by Type (2015-2020)
11.4 India NK Cell Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America NK Cell Therapy Market Size (2015-2020)
12.2 NK Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America NK Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America NK Cell Therapy Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Nektar Therapeutics
13.1.1 Nektar Therapeutics Company Details
13.1.2 Nektar Therapeutics Business Overview and Its Total Revenue
13.1.3 Nektar Therapeutics NK Cell Therapy Introduction
13.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2015-2020))
13.1.5 Nektar Therapeutics Recent Development
13.2 Innate Pharma SA
13.2.1 Innate Pharma SA Company Details
13.2.2 Innate Pharma SA Business Overview and Its Total Revenue
13.2.3 Innate Pharma SA NK Cell Therapy Introduction
13.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2015-2020)
13.2.5 Innate Pharma SA Recent Development
13.3 Affimed
13.3.1 Affimed Company Details
13.3.2 Affimed Business Overview and Its Total Revenue
13.3.3 Affimed NK Cell Therapy Introduction
13.3.4 Affimed Revenue in NK Cell Therapy Business (2015-2020)
13.3.5 Affimed Recent Development
13.4 Chipscreen Biosciences
13.4.1 Chipscreen Biosciences Company Details
13.4.2 Chipscreen Biosciences Business Overview and Its Total Revenue
13.4.3 Chipscreen Biosciences NK Cell Therapy Introduction
13.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2015-2020)
13.4.5 Chipscreen Biosciences Recent Development
13.5 Fate Therapeutics
13.5.1 Fate Therapeutics Company Details
13.5.2 Fate Therapeutics Business Overview and Its Total Revenue
13.5.3 Fate Therapeutics NK Cell Therapy Introduction
13.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2015-2020)
13.5.5 Fate Therapeutics Recent Development
13.6 Glycostem Therapeutics
13.6.1 Glycostem Therapeutics Company Details
13.6.2 Glycostem Therapeutics Business Overview and Its Total Revenue
13.6.3 Glycostem Therapeutics NK Cell Therapy Introduction
13.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2015-2020)
13.6.5 Glycostem Therapeutics Recent Development
13.7 Dragonfly Therapeutics
13.7.1 Dragonfly Therapeutics Company Details
13.7.2 Dragonfly Therapeutics Business Overview and Its Total Revenue
13.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction
13.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2015-2020)
13.7.5 Dragonfly Therapeutics Recent Development
13.8 Kiadis Pharma
13.8.1 Kiadis Pharma Company Details
13.8.2 Kiadis Pharma Business Overview and Its Total Revenue
13.8.3 Kiadis Pharma NK Cell Therapy Introduction
13.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2015-2020)
13.8.5 Kiadis Pharma Recent Development
13.9 NantWorks
13.9.1 NantWorks Company Details
13.9.2 NantWorks Business Overview and Its Total Revenue
13.9.3 NantWorks NK Cell Therapy Introduction
13.9.4 NantWorks Revenue in NK Cell Therapy Business (2015-2020)
13.9.5 NantWorks Recent Development
13.10 Nkarta Therapeutics
13.10.1 Nkarta Therapeutics Company Details
13.10.2 Nkarta Therapeutics Business Overview and Its Total Revenue
13.10.3 Nkarta Therapeutics NK Cell Therapy Introduction
13.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2015-2020)
13.10.5 Nkarta Therapeutics Recent Development
13.11 Fortress Biotech
10.11.1 Fortress Biotech Company Details
10.11.2 Fortress Biotech Business Overview and Its Total Revenue
10.11.3 Fortress Biotech NK Cell Therapy Introduction
10.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2015-2020)
10.11.5 Fortress Biotech Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global NK Cell Therapy Market Size, Status and Forecast 2020-2026
List of TablesTable 1. NK Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by NK Cell Therapy Revenue
Table 3. Ranking of Global Top NK Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of NK Cell Therapies
Table 6. Key Players of NK Cell Directed Antibodies
Table 7. Global NK Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global NK Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global NK Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global NK Cell Therapy Market Share by Regions (2015-2020)
Table 11. Global NK Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global NK Cell Therapy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. NK Cell Therapy Market Growth Strategy
Table 17. Main Points Interviewed from Key NK Cell Therapy Players
Table 18. Global NK Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 19. Global NK Cell Therapy Market Share by Players (2015-2020)
Table 20. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NK Cell Therapy as of 2019)
Table 21. Global NK Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players NK Cell Therapy Product Solution and Service
Table 24. Date of Enter into NK Cell Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global NK Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 27. Global NK Cell Therapy Market Size Share by Type (2015-2020)
Table 28. Global NK Cell Therapy Revenue Market Share by Type (2021-2026)
Table 29. Global NK Cell Therapy Market Size Share by Application (2015-2020)
Table 30. Global NK Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 31. Global NK Cell Therapy Market Size Share by Application (2021-2026)
Table 32. North America Key Players NK Cell Therapy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players NK Cell Therapy Market Share (2019-2020)
Table 34. North America NK Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 35. North America NK Cell Therapy Market Share by Type (2015-2020)
Table 36. North America NK Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. North America NK Cell Therapy Market Share by Application (2015-2020)
Table 38. Europe Key Players NK Cell Therapy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players NK Cell Therapy Market Share (2019-2020)
Table 40. Europe NK Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe NK Cell Therapy Market Share by Type (2015-2020)
Table 42. Europe NK Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe NK Cell Therapy Market Share by Application (2015-2020)
Table 44. China Key Players NK Cell Therapy Revenue (2019-2020) (Million US$)
Table 45. China Key Players NK Cell Therapy Market Share (2019-2020)
Table 46. China NK Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. China NK Cell Therapy Market Share by Type (2015-2020)
Table 48. China NK Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. China NK Cell Therapy Market Share by Application (2015-2020)
Table 50. Japan Key Players NK Cell Therapy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players NK Cell Therapy Market Share (2019-2020)
Table 52. Japan NK Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan NK Cell Therapy Market Share by Type (2015-2020)
Table 54. Japan NK Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan NK Cell Therapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players NK Cell Therapy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players NK Cell Therapy Market Share (2019-2020)
Table 58. Southeast Asia NK Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia NK Cell Therapy Market Share by Type (2015-2020)
Table 60. Southeast Asia NK Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia NK Cell Therapy Market Share by Application (2015-2020)
Table 62. India Key Players NK Cell Therapy Revenue (2019-2020) (Million US$)
Table 63. India Key Players NK Cell Therapy Market Share (2019-2020)
Table 64. India NK Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. India NK Cell Therapy Market Share by Type (2015-2020)
Table 66. India NK Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. India NK Cell Therapy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players NK Cell Therapy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players NK Cell Therapy Market Share (2019-2020)
Table 70. Central & South America NK Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America NK Cell Therapy Market Share by Type (2015-2020)
Table 72. Central & South America NK Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America NK Cell Therapy Market Share by Application (2015-2020)
Table 74. Nektar Therapeutics Company Details
Table 75. Nektar Therapeutics Business Overview
Table 76. Nektar Therapeutics Product
Table 77. Nektar Therapeutics Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 78. Nektar Therapeutics Recent Development
Table 79. Innate Pharma SA Company Details
Table 80. Innate Pharma SA Business Overview
Table 81. Innate Pharma SA Product
Table 82. Innate Pharma SA Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 83. Innate Pharma SA Recent Development
Table 84. Affimed Company Details
Table 85. Affimed Business Overview
Table 86. Affimed Product
Table 87. Affimed Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 88. Affimed Recent Development
Table 89. Chipscreen Biosciences Company Details
Table 90. Chipscreen Biosciences Business Overview
Table 91. Chipscreen Biosciences Product
Table 92. Chipscreen Biosciences Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 93. Chipscreen Biosciences Recent Development
Table 94. Fate Therapeutics Company Details
Table 95. Fate Therapeutics Business Overview
Table 96. Fate Therapeutics Product
Table 97. Fate Therapeutics Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 98. Fate Therapeutics Recent Development
Table 99. Glycostem Therapeutics Company Details
Table 100. Glycostem Therapeutics Business Overview
Table 101. Glycostem Therapeutics Product
Table 102. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 103. Glycostem Therapeutics Recent Development
Table 104. Dragonfly Therapeutics Company Details
Table 105. Dragonfly Therapeutics Business Overview
Table 106. Dragonfly Therapeutics Product
Table 107. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 108. Dragonfly Therapeutics Recent Development
Table 109. Kiadis Pharma Business Overview
Table 110. Kiadis Pharma Product
Table 111. Kiadis Pharma Company Details
Table 112. Kiadis Pharma Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 113. Kiadis Pharma Recent Development
Table 114. NantWorks Company Details
Table 115. NantWorks Business Overview
Table 116. NantWorks Product
Table 117. NantWorks Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 118. NantWorks Recent Development
Table 119. Nkarta Therapeutics Company Details
Table 120. Nkarta Therapeutics Business Overview
Table 121. Nkarta Therapeutics Product
Table 122. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 123. Nkarta Therapeutics Recent Development
Table 124. Fortress Biotech Company Details
Table 125. Fortress Biotech Business Overview
Table 126. Fortress Biotech Product
Table 127. Fortress Biotech Revenue in NK Cell Therapy Business (2015-2020) (Million US$)
Table 128. Fortress Biotech Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NK Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. NK Cell Therapies Features
Figure 3. NK Cell Directed Antibodies Features
Figure 4. Global NK Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Cancer Case Studies
Figure 6. Gastrointestinal Diseases Case Studies
Figure 7. Others Case Studies
Figure 8. NK Cell Therapy Report Years Considered
Figure 9. Global NK Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global NK Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global NK Cell Therapy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global NK Cell Therapy Market Share by Players in 2019
Figure 14. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NK Cell Therapy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2019
Figure 16. North America NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America NK Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Nektar Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 25. Innate Pharma SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 27. Affimed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Affimed Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 29. Chipscreen Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Chipscreen Biosciences Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 31. Fate Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 33. Glycostem Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 35. Dragonfly Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 37. Kiadis Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Kiadis Pharma Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 39. NantWorks Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. NantWorks Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 41. Nkarta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 43. Fortress Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Keyplayers in Global NK Cell Therapy Market Size, Status and Forecast 2020-2026
Nektar TherapeuticsInnate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech